Endovascular Thrombectomy Shows Promise for Large Infarct Cores
Recent studies indicate that endovascular thrombectomy may benefit patients with large ischemic strokes, challenging previous contraindications.
Endovascular thrombectomy (EVT) can improve outcomes for patients with large infarct cores.
Recent trials show comparable results between EVT and standard care for large strokes.
Concerns remain about the applicability of trial results to broader clinical practice.
A recent study has highlighted the potential of endovascular thrombectomy (EVT) for patients suffering from acute ischemic strokes with large infarct cores. Traditionally, the presence of a large ischemic core has been viewed as a contraindication for EVT, but emerging evidence suggests that patients with larger infarct volumes may still benefit from this intervention. The study, published in the International Journal of Stroke, analyzed data from the TENSION trial and the German Stroke Registry, focusing on patients who met the eligibility criteria for EVT.
Historically, EVT has revolutionized the treatment of ischemic strokes, significantly lowering both disability and mortality rates. Despite these advancements, many patients with large vessel occlusions remain untreated due to strict eligibility criteria. Current guidelines often require a National Institutes of Health Stroke Scale (NIHSS) score of 5 or higher and neuroimaging evidence of occlusion in major arteries. The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) is frequently used to assess the salvageable brain tissue, with a score of 6 or higher indicating potential for recovery.
In the study by Winkelmeier et al., researchers compared outcomes for 198 patients from the TENSION trial and the German Stroke Registry who underwent EVT. They found that, after propensity score matching, the clinical outcomes at 90 days post-stroke were similar between the two groups, suggesting that EVT could be effective even for those with larger infarct cores. However, the study also noted that only about half of the patients in the registry met the TENSION trial criteria, raising questions about the generalizability of these findings.
The implications of this research are significant for the treatment of stroke patients in clinical settings. While the results from the TENSION trial and the German Registry were comparable, the effectiveness of EVT in real-world scenarios remains uncertain. The study highlights the need for further research to understand how trial findings can be consistently applied in everyday clinical practice, particularly for patients with large infarct cores who may not fit traditional eligibility criteria.
Looking ahead, the medical community must address the hesitancy surrounding EVT for patients with large infarct cores. Future trials should aim for broader inclusion criteria that reflect the diversity of patients seen in clinical practice. Additionally, standardizing imaging protocols will be crucial to ensure accurate patient selection and improve outcomes for those suffering from acute ischemic strokes.
